Vicarious Surgical to Ring NYSE Closing Bell Today

Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT) celebrated its public listing by ringing the closing bell at the New York Stock Exchange on September 21, 2021. The company's merger with D8 Holdings Corp. was completed on September 17, 2021, and trading began on September 20, 2021. Vicarious Surgical aims to enhance surgical procedures' efficiency and patient outcomes using advanced robotics and virtual reality technology. The firm's innovative surgical approach has received FDA Breakthrough Device Designation, marking a significant milestone in minimally invasive surgical robotics.

Positive

• Merger with D8 Holdings Corp. completed on September 17, 2021.
• Public trading commenced on September 20, 2021, enhancing liquidity.
• FDA Breakthrough Device Designation received for surgical technology.

Negative

• None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, announced it will ring the closing bell at the New York Stock Exchange today, September 21, 2021, at 4 p.m. ET, in celebration of its public listing on the NYSE under the trading symbol “RBOT.”

“We are thrilled to celebrate this important milestone at the New York Stock Exchange,” said Adam Sachs, CEO and co-founder of Vicarious Surgical. “We remain steadfast in our mission to bring the benefits of minimally invasive surgical robotics to a broader base of patients.”

The closing bell ceremony will commence at 3:59 p.m. ET and interested parties may tune in to a live stream on the NYSE's website at: https://www.nyse.com/bell. Videos and photos during and following the ceremony will be shared on NYSE's Facebook pages, LinkedIn, and on Twitter @NYSE, as well as on Vicarious Surgical’s LinkedIn at Vicarious Surgical Inc. and on Twitter, @VicariousSurg.

Vicarious Surgical completed its merger with D8 Holdings Corp. on September 17, 2021, and began trading on September 20, 2021.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005367/en/

Investor Inquiries:

Marissa Bych

Gilmartin Group LLC

ir@vicarioussurgical.com



Press and Media Inquiries:

Jill Gross

Matter Communications

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

FAQ

What is Vicarious Surgical's stock symbol?

Vicarious Surgical's stock symbol is RBOT, and its warrants trade under RBOT WS.

When did Vicarious Surgical ring the NYSE closing bell?

Vicarious Surgical rang the NYSE closing bell on September 21, 2021.

When did Vicarious Surgical start trading on the NYSE?

Vicarious Surgical began trading on the NYSE on September 20, 2021.

What significant designation did Vicarious Surgical's technology receive?

Vicarious Surgical's surgical technology received FDA Breakthrough Device Designation.